Elizabeth Becker
Physician Assistant · Erie, PANPI 1235839861
Payments from drug & device makers
Across 351 payments — averaging $14.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dexcom, Inc.$1K
- Novo Nordisk$798
- Lilly USA, LLC$396
- Madrigal Pharmaceuticals$328
- Amgen$313
- Corcept Therapeutics$196
- plus $1K from 22 others
What the payments were for
- Food & beverage$4,911100%
- Education$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dexcom, Inc. | 161 | $1,407 |
| Novo Nordisk | 42 | $798 |
| Lilly USA, LLC | 22 | $396 |
| Madrigal Pharmaceuticals | 25 | $328 |
| Amgen(2 entities) | 11 | $313 |
| Corcept Therapeutics | 16 | $196 |
| Boehringer Ingelheim | 4 | $149 |
| Medtronic | 3 | $122 |
| Amneal Pharmaceuticals LLC | 6 | $118 |
| Sanofi-aventis U.S. LLC | 6 | $117 |
| Xeris Pharmaceuticals, Inc. | 6 | $117 |
| Tandem Diabetes Care, Inc. | 13 | $99 |
| Neurocrine Biosciences, Inc. | 5 | $98 |
| AbbVie | 5 | $90 |
| Azurity Pharmaceuticals, Inc. | 5 | $83 |
| Sequel Med Tech, LLC | 1 | $73 |
| Kyowa Kirin, Inc. | 3 | $71 |
| Antares Pharma, Inc. | 4 | $70 |
| AstraZeneca(2 entities) | 3 | $63 |
| Radius Health, Inc. | 1 | $50 |
| Tolmar, Inc. | 2 | $42 |
| Halozyme Inc | 1 | $24 |
| Pfizer | 1 | $22 |
| Insulet Corporation | 1 | $18 |
| Smith+Nephew | 1 | $16 |
| Bayer | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Recordati_rare_diseases_inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wegovy$125
- TEPEZZA$125
- DEXCOM G7 GSS (161)$112
- REZDIFFRA$104
- JARDIANCE$103
How this compares
$4,927 in reported general payments places this provider in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 242 | $397,546 |
| JardianceEmpagliflozin | 143 | $160,159 |
| MounjaroTirzepatide | 106 | $143,464 |
| TrulicityDulaglutide | 28 | $53,484 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 89 | $45,064 |
| Novolog FlexpenInsulin Aspart | 106 | $32,282 |
| Humalog Kwikpen U-100Insulin Lispro | 91 | $29,813 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 187 | $29,591 |
| Tresiba Flextouch U-200Insulin Degludec | 26 | $29,244 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 27 | $28,394 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 23 | $27,337 |
| JanuviaSitagliptin Phosphate | 22 | $26,862 |
| FarxigaDapagliflozin Propanediol | 20 | $26,610 |
| Tresiba Flextouch U-100Insulin Degludec | 46 | $24,140 |
| TradjentaLinagliptin | 26 | $21,534 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Novolog | $798 | $408,974269 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $396 | $202,784156 claims |
| Boehringer IngelheimJardiance, Tradjenta | $149 | $181,693169 claims |
| AstraZenecaFarxiga | $63 | $26,61020 claims |
| AmgenProlia | $313 | $20,80613 claims |
| AbbVieSynthroid | $90 | $18,339226 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus | $117 | $14,85331 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $118 | $3,373293 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.
Other physician assistant in Erie
- Allison BoydErie$163K
- Daniel TelegaErie$124K
- Erin CrownState College$1.5M
- Tricia BootsCranberry Twp$313K
- Melissa FerrariPhiladelphia$223K
- Jason OberdickWexford$206K
- Justine RobertsMurrysville$173K
- Joshua TrbovichWashington$144K
- Alvin KingcadePhiladelphia$101K
- Jeffrey CameronWashington$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.